Injection Lipolysis
30.03.2016
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
08.06.2016
Natural killer cells have a memory
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin. It […]
24.05.2016
Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations
Almirall S.A., the global pharmaceutical company based in Barcelona, and Bicosome, a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients, announced that they have entered into […]